Cyclin-dependent kinases (Cdks) are key regulators of cell cycle progression and are therefore promising therapeutic targets for cancer and neurodegenerative diseases. CAY10554 is a potent inhibitor of Cdk5 and Cdk2, with IC50 values of 64 and 98 nM, respectively.1
1
Helal, C.J., Sanner, M.A., Cooper, C.B., et al. Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease. Bioorg Med Chem Lett145521-5525(2004).
Room temperature
in continental US; may vary elsewhere
SMILES
Copy SMILES to clipboard
O=C(Cc1ccccc1)Nc1ncc(s1)C(C)C
Background Reading
Helal, C.J., Sanner, M.A., Cooper, C.B., et al. Discovery and SAR of 2-aminothiazole inhibitors of cyclin-dependent kinase 5/p25 as a potential treatment for Alzheimer’s disease. Bioorg Med Chem Lett145521-5525(2004).
Size
Price
Quantity
Subtotal
5 mg
$51.00
$0.00
10 mg
$97.00
$0.00
25 mg
$230.00
$0.00
50 mg
$408.00
$0.00
Bulk
Contact
Cart Total
$0.00
This product is available in custom sizes and/or larger quantities.